Page 2 - Reichstein Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Arthrosi Therapeutics, a clinical-stage biotechnology company, today announced the successful securing of $75 million in Series D financing..

Hong kongSan diegoUnited statesLitain yehShunqi yanHanxiong liApichope pharmaceuticalsIndustry hong kong coShenzhen stock exchangeReichstein biotech hk coArthrosi therapeutics incReichstein biotechHope pharmaceutical